Concentra Group Parent I... (CON)

ADDISON, Texas--(BUSINESS WIRE)--Concentra® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors,...

Kronos Bio completed its sale to Concentra Biosciences for 57 cents a share in cash plus contingent value rights related to cost savings and potential proceeds from disposition of drug candidates.

Investors looking for stocks in the Medical Services sector might want to consider either Concentra Group (CON) or Medpace (MEDP). But which of these two stocks is more attractive to value investors?

The average of price targets set by Wall Street analysts indicates a potential upside of 27.1% in Concentra (CON). While the effectiveness of this highly sought-after metric is questionable, the posit...

Concentra (CON) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ADDISON, Texas--(BUSINESS WIRE)--Concentra® (NYSE: CON) the nation's leader in occupational medicine, today announced the opening of a new medical center in Chattanooga, Tennessee. The medical center,...

Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the bette...

The mean of analysts' price targets for Concentra (CON) points to a 30.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analyst...

Concentra Group (CON) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.47 per share a year ago.

ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation's largest provider of occupational health services, to...